Mss51 deletion increases endurance and ameliorates histopathology in the mdx mouse model of Duchenne muscular dystrophyFASEB JOURNALIF4.22021-01-108PRE
Duchenne muscular dystrophy hiPSC-derived myoblast drug screen identifies compounds that ameliorate disease in mdx miceJCI INSIGHTIF6.12020-04-2826OA
Mss51 deletion enhances muscle metabolism and glucose homeostasis in miceJCI INSIGHTIF6.12019-10-1718OA
In vitro cytokine licensing induces persistent permissive at the Indoleamine 2,3-dioxygenase promoterCYTOTHERAPYIF3.22016-09-0131OAAI
Chromatin Changes at the PPAR-γ2 Promoter During Bone Marrow-Derived Multipotent Stromal Cell Culture Correlate With Loss of Gene Activation PotentialStem CellsIF3.62015-05-2612PREAI
Overcoming Antigenic Diversity by Enhancing the Immunogenicity of Conserved Epitopes on the Malaria Vaccine Candidate Apical Membrane Antigen-1PLOS PATHOGENSIF4.92013-12-2678OAAI